Aster Capital Management (Difc) LTD Intellia Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 332 shares of NTLA stock, worth $2,788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
332Holding current value
$2,788% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
335Shares Held
95.4MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$105 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$85.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$80.6 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$43.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$32 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $638M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...